Vaccines Against Infectious Diseases and Cancers
Vaccines against infectious diseases represent a therapeutic vaccine against chronic infectious diseases aim at eliciting broad humoral and cellular immune responses against multiple target antigens. The development of these vaccines will help to establish substitute markers of protection in humans and thus will boost the subsequent development of capable prophylactic vaccines. A grouping of synthetic small-molecule drugs andimmunotherapeutics is likely to represent a powerful means of controlling chronic infections in the future. There are a number of scientific challenges which require multidisciplinary teams to solve problems in developing new immunogens. This has challenged our existing knowledge about protein structure and conformation, microbial pathogenicity and the immune system. Cancer cells are generally ignored by the immune system. This is because for the most of the part are more closely resemble cells that belong in the body than pathogens, such as bacterial cells or viruses. The goal of cancer vaccines is to provoke the immune system to identify cancercells as foreign and attack them.
Related Conference of Vaccines Against Infectious Diseases and Cancers
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Vaccines Against Infectious Diseases and Cancers Conference Speakers
Recommended Sessions
- Allergic Asthma Treatment and Prevention
- Child Vaccination & Immunization / Pediatric Vaccines
- Mucosa immunization Industries
- Mucosal Diseases
- Mucosal Immunity and Vaccines
- Mucosal Immunology in Urology
- Mucosal Immunology of HIV Infection
- Mucosal Immunology of Host Defenses
- Mucosal Immunology of Infectious Diseases
- Mucosal Immunology of Parasitic Diseases
- Mucosal Melanoma
- Mucosal Vaccination
- Mucosal Vaccines Adjuvants
- Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions
- Sinus Mucosal
- Vaccine Delivery Systems
- Vaccines Against Infectious Diseases and Cancers
- Veterinary Vaccines
Related Journals
Are you interested in
- Allergy, Hypersensitivity & Immune Tolerance - Immunology 2026 (France)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Autoimmune & Inflammatory Disorders - Immunology 2026 (France)
- Cancer Immunology & Tumor Microenvironment - Immunology 2026 (France)
- Cellular Signaling & Cell Fate Determination - Immunology 2026 (France)
- Clinical and Translational Immunology - Immunology 2026 (France)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunogenetics & Epigenetic Regulation - Immunology 2026 (France)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism - Immunology 2026 (France)
- Immunotherapy & Immune Modulation - Immunology 2026 (France)
- Infectious Diseases - Antibiotics 2026 (UK)
- Infectious Diseases & Host–Pathogen Interactions - Immunology 2026 (France)
- Innate and Adaptive Immune Mechanisms - Immunology 2026 (France)
- Innovations in Cell Biology & Imaging Technologies - Immunology 2026 (France)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular & Cellular Immunology - Immunology 2026 (France)
- Neuroimmunology & Brain–Immune Interactions - Immunology 2026 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Stem Cells & Regenerative Immunology - Immunology 2026 (France)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Vaccines & Vaccine Technology - Immunology 2026 (France)
